Sylvia M. Wilson

发表

Serial Plasma Osteopontin Levels Have Prognostic Value in Metastatic Breast Cancer

V. Bramwell, A. Chambers, T. Vandenberg, 2006, Clinical Cancer Research.

New dual monoclonal ELISA for measuring plasma osteopontin as a biomarker associated with survival in prostate cancer: clinical validation and comparison of multiple ELISAs.

L. Stitt, A. Chambers, M. Maeda, 2009, Clinical chemistry.

Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells

M. C. Ling, F. O'Malley, A. Chambers, 1999, Oncogene.

Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo

R. Khokha, A. Chambers, Sylvia M. Wilson, 1992, Clinical & Experimental Metastasis.

Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer

V. Bramwell, A. Chambers, T. Vandenberg, 2009, Breast Cancer Research and Treatment.

Effect of (cid:1) 2 -adrenoceptor agonists and other cAMP-elevating agents on inﬂammatory gene expression in human ASM cells: a role for protein kinase A

K. Chung, P. Barnes, N. Holden, 2008 .

Plasma osteopontin

L. Stitt, A. Chambers, S. Hotte, 2002, Cancer.

Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model.

A. Chambers, C. Postenka, A. Tuck, 2005, Cancer research.

4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-benzyl)-phenyl]-amine (RO1138452) Is a Selective, Pseudo-Irreversible Orthosteric Antagonist at the Prostacyclin (IP)-Receptor Expressed by Human Airway Epithelial Cells: IP-Receptor-Mediated Inhibition of CXCL9 and CXCL10 Release

D. Proud, M. Giembycz, Sylvia M. Wilson, 2008, Journal of Pharmacology and Experimental Therapeutics.

RO 1138452 is a selective , pseudo-irreversible orthosteric antagonist at the prostacyclin ( IP )-receptor expressed by human airway epithelial cells : negative IP-receptor-mediated regulation of CXCL 9 and CXCL 10 release

D. Proud, M. Giembycz, Sylvia M. Wilson, 2007 .

Evidence for a Second Receptor for Prostacyclin on Human Airway Epithelial Cells That Mediates Inhibition of CXCL9 and CXCL10 Release

R. Newton, M. Giembycz, Sylvia M. Wilson, 2011, Molecular Pharmacology.

Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways

A. Chambers, A. Tuck, Sylvia M. Wilson, 2003, Oncogene.

Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expression

J. Cairncross, A. Chambers, G. Denhardt, 1991, Journal of Neuro-Oncology.

Gene expression and metastasis of somatic cell hybrids between murine fibroblast cell lines of different malignant potential

A. Chambers, A. Tuck, Sylvia M. Wilson, 1991, Somatic cell and molecular genetics.

Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines

V. Morris, A. Chambers, A. Tuck, 2004, Clinical & Experimental Metastasis.

Activated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases.

I. Macdonald, A. Chambers, A. Groom, 2002, Cancer research.

Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy.

G. Naumov, I. Macdonald, N. Kerkvliet, 2002, Cancer research.

SnoN Is a Cell Type-specific Mediator of Transforming Growth Factor-β Responses*

Sylvia M. Wilson, K. Sarker, S. Bonni, 2005, Journal of Biological Chemistry.

Expression of osteopontin and HGF/Met in adult soft tissue tumors

L. Stitt, V. Bramwell, A. Chambers, 2005, Cancer biology & therapy.

ras mutation and expression of the ras‐regulated genes osteopontin and cathepsin L in human esophageal cancer

M. Tsao, F. O'Malley, H. Ozçelik, 1997, International journal of cancer.

Use of NeoR B16F1 murine melanoma cells to assess clonality of experimental metastases in the immune-deficient chick embryo

A. Chambers, Sylvia M. Wilson, 1988, Clinical & Experimental Metastasis.

Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.

A. Chambers, C. Postenka, A. Tuck, 2003, Molecular cancer research : MCR.

Experimental Metastasis Assays in the Chick Embryo

A. Chambers, Sylvia M. Wilson, Ann F Chambers, 2003, Current protocols in cell biology.

Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases

F. O'Malley, V. Bramwell, A. Chambers, 1998, The Lancet.

Selective Prostacyclin Receptor Agonism Augments Glucocorticoid-Induced Gene Expression in Human Bronchial Epithelial Cells1

D. Proud, R. Newton, M. Giembycz, 2009, The Journal of Immunology.

CellsExpression in Human Bronchial Epithelial Augments Glucocorticoid-Induced Gene Selective Prostacyclin Receptor Agonism

D. Proud, R. Newton, Sylvia M. Wilson, 2009 .

Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases

Jason L. Townson, G. Naumov, V. Bramwell, 2003, Breast Cancer Research and Treatment.

SnoN is a cell type-specific mediator of transforming growth factor-beta responses.

Sylvia M. Wilson, K. Sarker, S. Bonni, 2005, The Journal of biological chemistry.

Phosphodiesterase 4 Inhibitors Augment the Ability of Formoterol to Enhance Glucocorticoid-Dependent Gene Transcription in Human Airway Epithelial Cells: A Novel Mechanism for the Clinical Efficacy of Roflumilast in Severe Chronic Obstructive Pulmonary Disease

R. Newton, T. Joshi, M. Giembycz, 2013, Molecular Pharmacology.

Osteopontin expression in lung cancer.

J. F. Harris, F. O'Malley, N. Kerkvliet, 1996, Lung cancer.

R. Newton, T. Joshi, M. Giembycz, 2013, Molecular Pharmacology.

Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis.

G. Naumov, R. Hoffman, I. Macdonald, 1999, Journal of cell science.